Previous 10 | Next 10 |
2023-11-08 08:34:45 ET Lumos Pharma ( LUMO ) +36% Q3 earnings call release Target Hospitality ( TH ) +25% Q3 earnings call release Baiyu Holdings ( BYU ) +23% . Upwork ( UPWK ) +23% Q3 earnings call release EVgo ( E...
2023-11-07 14:22:10 ET Cellectis SA (CLLS) Q3 2023 Earnings Conference Call November 07, 2023, 08:00 ET Company Participants Arthur Stril - Chief Business Officer Andre Choulika - Co-founder, CEO& Director Mark Frattini - Chief Medical Officer Bing Wang -...
2023-11-06 17:24:57 ET Cellectis ( NASDAQ: CLLS ): Q3 Non-GAAP EPS of -$0.58. Revenue of $1.88M (+14.6% Y/Y). Cash position of $72 million as of September 30, 2023. Cash runway into 2026. For further details see: Cellectis Non-GAAP EPS of -$0.58, revenue of $...
• Strategic Collaboration and Investment Agreements signed with AstraZeneca Updated results of the Phase I BALLI-01 Trial evaluating UCART22 in r/r B-cell ALL and preliminary results of the Phase I NATHALI-01 Trial evaluating UCART20x22 in r/r B-cell NHL to be presented at ...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...
2023-11-05 17:35:55 ET Major earnings expected after the bell on Monday include: Realty Income Corporation ( O ) Vertex Pharmaceuticals Incorporated ( VRTX ) NXP Semiconductors N.V. ( NXPI ) Alteryx ( AYX ) Tanger Factory Outlet Centers ( SKT ) ...
2023-11-03 18:57:50 ET Summary Preliminary data from two early-stage studies are going to be shown at the ASH 2023 conference, showcasing its cell therapy candidates for non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia. The company recently entered into a collaboration...
2023-11-03 14:08:27 ET DENVER, Colo., Nov 3, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; Verve Therapeutics Inc (NASDAQ: VERV), Cellectis (NASDAQ: CLLS), Palantir Technologies (NYSE: PLTR), Werewolf Therapeutics (N...
2023-11-03 10:02:39 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: Cellectis, VYNE Therapeutics among healthcare movers
2023-11-03 08:22:27 ET More on pre-market losers stock Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings Acurx Pharma falls after mid-stage data for lead asset AstraZeneca to invest $245M in Cellectis to strengthen gene therapy portfolio ...
News, Short Squeeze, Breakout and More Instantly...
Cellectis S.A. Company Name:
CLLS Stock Symbol:
NASDAQ Market:
JD.com Inc. (JD) is expected to report $0.56 for Q1 2024 Volkswagen AG (VLKAF) is expected to report for Q1 2024 CalAmp Corp. (CAMP) is expected to report for Q4 2024 Sonic Foundry Inc. (SOFO) is expected to report for Q2 2024 Moatable Inc ADR (R2RS:MU) is expected to report for Q...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 20...